P. Silver

A. Daud, J. Fareed, O. Iqbal, 2001, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Biochemical aspects of inhibition of cardiovascular low (Km) cyclic adenosine monophosphate phosphodiesterase.

P. Silver, 1989, The American journal of cardiology.

Phosphodiesterase isozyme inhibition, activation of the cAMP system, and positive inotropy mediated by milrinone in isolated guinea pig cardiac muscle.

R. Bentley, D. B. Evans, P. Canniff, 1989, Journal of cardiovascular pharmacology.

Comparison of urinary desmosine excretion in patients with chronic obstructive pulmonary disease or cystic fibrosis.

D. C. Bode, P. Silver, L. Hamel, 2000, Pulmonary pharmacology & therapeutics.

Pulmonary Hemorrhage Induced by Intratracheal Administration of Human Leukocyte Elastase in Hamsters

R. Gordon, P. Silver, E. Ferguson, 1991, Annals of the New York Academy of Sciences.

Phosphorylation of myosin light chain and phosphorylase in tracheal smooth muscle in response to KCl and carbachol.

J. Stull, P. Silver, 1984, Molecular pharmacology.

Optimizing organization and effectiveness of pharmaceutical discovery by molecular target rather than by therapeutic area

P. Silver, 1994 .

Adenosine-mediated relaxation and activation of cyclic AMP-dependent protein kinase in coronary arterial smooth muscle.

P. Silver, J. Disalvo, K. Walus, 1984, The Journal of pharmacology and experimental therapeutics.

Comparative hemodynamic and renal effects of the low Km cGMP phosphodiesterase inhibitors cicletanine and zaprinast in anesthetized dogs

P. Canniff, P. Silver, E. Pagani, 1991 .

Cardiovascular effects of medorinone in β‐adrenoreceptor‐blocked and non‐blocked anesthetized dogs

P. Canniff, P. Silver, E. Pagani, 1990 .

Pharmacological modulation of phosphorylation mechanisms in heart and vasculature

P. Silver, 1988 .

Regulation of Myosin Phosphorylation in Smooth Muscle

J. Stull, P. Silver, J. Miller, 1984 .

Evidence for multiple antiarrhythmic binding sites on the cardiac rapidly activating delayed rectifier K+ channel

P. Silver, W. Volberg, D. Krafte, 1995 .

Pharmacological modulation of human cardiac Na+ channels.

R. Kallen, P. Silver, R. Barchi, 1994, European journal of pharmacology.

The effects of iodixanol and iopamidol on hemodynamic and cardiac electrophysiologic parameters in vitro and in vivo.

R. Dundore, G. V. Van Aller, P. Silver, 1991, Investigative radiology.

Neutralase reverses the anti-coagulant but not the anti-thrombotic activity of heparin in a rabbit model of venous thrombosis.

P. Silver, A. M. Wallace, J. Bouthillier, 1998, Thrombosis Research.

The role of myosin light chain kinase phosphorylation in beta-adrenergic relaxation of tracheal smooth muscle.

J. Stull, P. Silver, J. Miller, 1983, Molecular pharmacology.

Enhanced phosphorylation of arterial particulate proteins by cyclic nucleotides and human atrial natriuretic factor.

P. Silver, P. B. Pinto, S. M. Kocmund, 1986, European journal of pharmacology.

Inhibition of cardiovascular low‐Km cAMP phosphodiesterase activity by medorinone

R. Bentley, M. Connell, P. Silver, 1990 .

Myosin light chain phosphorylation in smooth muscle and nonmuscle cells as a probe of calmodulin function.

J. Stull, P. Silver, 1983, Methods in enzymology.

Inhibition of low Km cGMP phosphodiesterases and Ca+(+)-regulated protein kinases and relationship to vasorelaxation by cicletanine.

R. Bentley, G. V. Van Aller, P. Silver, 1991, The Journal of pharmacology and experimental therapeutics.

Inhibition of Low Km Cyclic GMP Phosphodiesterases and Potentiation of Guanylate Cyclase Activators by Cicletanine

R. Dundore, P. Silver, A. Harris, 1990, Journal of cardiovascular pharmacology.

Zaprinast increases cyclic GMP levels in plasma and in aortic tissue of rats.

R. Dundore, D. C. Bode, P. Silver, 1993, European journal of pharmacology.

Natriuretic and diuretic effects of cicletanine in conscious, hydrated, normotensive rats

P. Silver, R. Buchholz, A. Brousseau, 1992 .

Effects of nucleotide cyclase activators on the depressor response to selective low Km cyclic AMP phosphodiesterase inhibitors in rats

P. Pratt, P. Silver, R. Buchholz, 1991 .

Sodium nitroprusside potentiates the depressor response to the phosphodiesterase inhibitor zaprinast in rats.

P. Pratt, R. Dundore, P. Silver, 1990, European journal of pharmacology.

Antidepressants and protein kinases: inhibition of Ca2+-regulated myosin phosphorylation by fluoxetine and iprindole.

P. Silver, J. Moyer, E. Sigg, 1986, European journal of pharmacology.

Effects of felodipine, nitrendipine and W-7 on arterial myosin phosphorylation, actin-myosin interactions and contraction.

J. Ambrose, P. Silver, R. Michalak, 1984, European journal of pharmacology.

Drug action and cellular calcium regulation

D. Triggle, P. Silver, R. Janis, 1987 .

4,5-Dihydro-3-(methanesulfonamidophenyl)-1-phenyl-1H-2,4-benzodiazepines: a novel class III antiarrhythmic agents.

G. M. Briggs, G M Briggs, R. E. Johnson, 1995, Journal of medicinal chemistry.

Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle.

R. Bentley, D. B. Evans, P. Silver, 1988, European journal of pharmacology.

Tetrahydropyrrolo[1,2-a]quinoxalines and tetrahydropyrrolo[1,2-a]pyrido[3,2-a]pyrazines: vascular smooth muscle relaxants and antihypertensive agents.

M. Abou-Gharbia, P. Silver, R. Mccaully, 1984, Journal of medicinal chemistry.

Role of cyclic AMP protein kinase in decreased arterial cyclic AMP responsiveness in hypertension.

P. Silver, R. Michalak, S. M. Kocmund, 1985, The Journal of pharmacology and experimental therapeutics.

Low molecular weight analogs of trolox with potent antioxidant activity in vitro and in vivo

P. Silver, W. Gorczyca, R. Gordon, 1992 .

beta-Adrenergic relaxation and cAMP kinase activation in coronary arterial smooth muscle.

P. Silver, J. Disalvo, C. Schmidt-Silver, 1982, American Journal of Physiology.

Adenosine 3':5'-monophosphate-mediated inhibition of myosin light chain phosphorylation in bovine aortic actomyosin.

P. Silver, J. Disalvo, 1979, The Journal of biological chemistry.

Differential Vasorelaxant Effects of Milrinone and Amrinone on Contractile Responses of Canine Coronary, Cerebral, and Renal Arteries

P. Silver, A. Harris, A. Alousi, 1989, Journal of cardiovascular pharmacology.

Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone.

R. Bentley, P. Silver, A. Harris, 1988, The Journal of pharmacology and experimental therapeutics.

Antidepressants and protein kinases: desipramine treatment affects pineal gland cAMP-dependent protein kinase activity.

P. Silver, J. Moyer, E. Sigg, 1986, European journal of pharmacology.

Differential effects of pharmacological modulators of cardiac myofibrillar ATPase activity in normal and myopathic (BIO 14.6) hamsters.

P. Silver, P. Monteforte, 1988, European journal of pharmacology.

Ca2+ Dependent Phosphorylation of Bovine Aortic Actomyosin 1

E. Gruenstein, P. Silver, J. Disalvo, 1978, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Protein kinase inhibitors and blood pressure control in spontaneously hypertensive rats.

R. Dundore, P. Silver, A. Harris, 1991, Hypertension.

Regulation of contractile activity in vascular smooth muscle by protein kinases.

P. Silver, 1985, Reviews in clinical & basic pharmacology.

Chapter 28 – Pharmacological Regulation of Smooth Muscle by Ion Channels, Kinases, and Cyclic Nucleotides

P. Silver, D. Krafte, 1996 .

Gastric half emptying time (T½) for 4‐h gastric emptying scintigraphy simplifies reporting but reduces detection of gastroparesis

A. Maurer, H. Parkman, P. Silver, 2021, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Cardiovascular cyclic nucleotide phosphodiesterases and their role in regulating cardiovascular function.

P. Silver, R. Buchholz, E. Pagani, 1992, Basic research in cardiology.

Calcium transport by sarcoplasmic reticulum of vascular smooth muscle: II. Effects of calmodulin and calmodulin inhibitors

P. Silver, M. A. Stout, 1992, Journal of cellular physiology.

Imidazotriazinone inhibitors of the Ca2+-calmodulin sensitive phosphodiesterase (PDE I)

D. Hlasta, D. C. Bode, P. Silver, 1997 .

Hemodynamic and Renal Effects of the Protein Kinase Inhibitor Staurosporine in Conscious Rats

P. Pratt, R. Dundore, P. Silver, 1992, Journal of cardiovascular pharmacology.

Perhexiline directly inhibits arterial myosin phosphorylation and stimulates cardiac myofibrillar ATPase activity.

P. Silver, 1984, European journal of pharmacology.

Uptake of cicletanine by vascular smooth muscle

P. Silver, Wayne R. Cumiskey, 1991 .

Reversal or nitroglycerin tolerance by the cGMP phosphodiesterase inhibitor zaprinast.

P. Pratt, G. V. Van Aller, L. de Garavilla, 1991, European journal of pharmacology.

Lack of cross-tolerance between nitroglycerin and endothelium-derived relaxing factor-mediated vasoactive agents in spontaneously hypertensive rats.

P. Pratt, L. de Garavilla, P. Silver, 1993, European journal of pharmacology.

Interaction of the beta adrenergic receptor antagonist bucindolol with serotonergic receptors.

G. Fink, S. Watts, P. Silver, 2000, Journal of cardiovascular pharmacology.

Cardiovascular activity of WIN 65579, a novel inhibitor of cyclic GMP phosphodiesterase 5.

E. Bacon, R. Dundore, D. C. Bode, 1998, European journal of pharmacology.

Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle.

R. Bentley, P. Silver, A. Harris, 1989, The Journal of pharmacology and experimental therapeutics.

Cyclic GMP potentiation by WIN 58237, a novel cyclic nucleotide phosphodiesterase inhibitor.

G. Y. Lesher, E. Bacon, R. Dundore, 1994, The Journal of pharmacology and experimental therapeutics.

Effects of calcium antagonists and vasodilators on arterial myosin phosphorylation and actin-myosin interactions.

J. Ambrose, P. Silver, J. Dachiw, 1984, The Journal of pharmacology and experimental therapeutics.

Cellular distribution and pharmacological sensitivity of low Km cyclic nucleotide phosphodiesterase isozymes in human cardiac muscle from normal and cardiomyopathic subjects.

R. Bentley, J. Etzler, P. Allen, 1990, Second messengers and phosphoproteins.

IBT 9302 (Heparinase III): a novel enzyme for the management of reperfusion injury-related vascular damage, restenosis and wound healing.

P. Silver, 1998, Expert opinion on investigational drugs.

In vivo and in vitro effects of the novel antiarrhythmic ipazilide on cardiac and vascular smooth muscle function

P. Silver, A. Harris, A. Ezrin, 1992 .

Proximal and distal intragastric meal distribution during gastric emptying scintigraphy: Relationships to symptoms of gastroparesis

A. Maurer, H. Parkman, P. Silver, 2022, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Calcium-regulated protein kinases and low Km cGMP phosphodiesterases: targets for novel antihypertensive therapy.

R. Dundore, P. Silver, A. Harris, 1991, Advances in experimental medicine and biology.

Peripheral benzodiazepine receptor binding properties and effects on steroid synthesis of two new phenoxyphenyl‐acetamide derivatives, DAA1097 and DAA1106

M. Gazouli, V. Papadopoulos, S. Okuyama, 2001 .

Novel cAMP PDE III inhibitors: 1,6-naphthyridin-2(1H)-ones.

R. Bentley, M. Connell, G. Y. Lesher, 1992, Journal of medicinal chemistry.

Biological activity of WIN 63759, an orally bioavailable inhibitor of human neutrophil elastase

D. Hlasta, A. Maycock, J. Newton, 1995 .

The Regulation of Myosin Light Chain Kinase by Ca++ and Calmodulin in Vitro and in Vivo

D. Blumenthal, J. Stull, P. Silver, 1982 .

Effects of the calmodulin antagonist, fluphenazine, on phosphorylation of myosin and phosphorylase in intact smooth muscle.

J. Stull, P. Silver, 1983, Molecular pharmacology.

Pharmacological Modulation of Cardiac and Vascular Contractile Protein Function

P. Silver, 1986, Journal of cardiovascular pharmacology.

Identification of a specific radioligand for the cardiac rapidly activating delayed rectifier K+ channel.

G M Briggs, P J Silver, C C Chadwick, 1993, Circulation research.